[Use of lithium oxybutyrate for improving results in the early post-operative period in lung cancer patients]

V V Leonenkov; I V Dunaevskiĭ; N I Semigolovskiĭ; A S Barchuk; A I Evtiukhin; A L Kostiuchenko

[Use of lithium oxybutyrate for improving results in the early post-operative period in lung cancer patients]

Vopr Onkol. 1993;39(1-3):75-9.

[Article in Russian]

Authors

V V Leonenkov, I V Dunaevskiĭ, N I Semigolovskiĭ, A S Barchuk, A I Evtiukhin, A L Kostiuchenko

PMID: 8073681

Abstract

Application of antihypoxant drugs in postoperative period has been investigated. Lithium oxybutyrate was administered to 30 lung cancer patients before and shortly after operation. The results were compared with the data on 26 patients in control. Major characteristics, and, primarily, its antihypoxic protective effect have been evaluated. Lithium oxybutyrate administration is recommended in lung cancer patients during and shortly after surgery.

Publication types

Clinical Trial

MeSH terms

Female
Humans
Hydroxybutyrates / therapeutic use*
Hypoxia / etiology
Hypoxia / prevention & control*
Lithium
Lung Neoplasms / complications
Lung Neoplasms / surgery*
Male
Middle Aged
Organometallic Compounds / therapeutic use*
Postoperative Care
Preoperative Care
Surgical Procedures, Operative / adverse effects

Substances

Hydroxybutyrates
Organometallic Compounds
lithium hydroxybutyrate
Lithium